• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    24 Stocks Moving in Tuesday's Pre-Market Session

    6/21/22 6:04:07 AM ET
    $ALV
    $ATHX
    $BHAT
    $CASI
    Auto Parts:O.E.M.
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ALV alert in real time by email

    Gainers

    • Valneva SE (NASDAQ:VALN) shares rose 83.6% to $25.18  in pre-market trading following Pfizer agreement to acquire an 8.1% stake.
    • Grove Collaborative Holdings, Inc. (NASDAQ:GROV) rose 44.8% to $14.48 in pre-market trading after jumping 68% on Friday.
    • Minerva Neurosciences, Inc. (NASDAQ:NERV) rose 36.7% to $0.54 in pre-market trading.
    • Endo International plc (NASDAQ:ENDP) shares rose 23.1% to $0.4315 in pre-market trading. TLC BioSciences recently entered a commercialization agreement with Endo International for the U.S. rights of TLC599, a proprietary BioSeizer sustained-release injectable in Phase 3 development for osteoarthritis pain.
    • RedHill Biopharma Ltd. (NASDAQ:RDHL) rose 19.4% to $0.76 in pre-market trading. RedHill Biopharma is expected to report its first quarter 2022 financial results and operational highlights on Thursday, June 23, 2022.
    • Mereo BioPharma Group plc (NASDAQ:MREO) rose 16.9% to $1.52 in pre-market trading. Mereo BioPharma shares jumped over 62% on Friday following reports suggesting AstraZeneca is weighing a bid for Mereo BioPharma.
    • Revlon, Inc. (NYSE:REV) rose 13.4% to $4.23 in pre-market trading. Revlon shares jumped 91% on Friday following a report suggesting Reliance Industries is considering buying out the company, which recently filed for bankruptcy.
    • Spirit Airlines, Inc. (NYSE:SAVE) rose 12.7% to $24.00 in pre-market trading. Spirit Airlines’ board announced they will review revised proposal from JetBlue Airways Corporation.
    • Resolute Forest Products Inc. (NYSE:RFP) shares rose 12.4% to $15.50 in pre-market trading. The company, last month, posted downbeat quarterly earnings.
    • Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) rose 10.7% to $0.7749 in pre-market trading. Hepion Pharmaceuticals received FDA orphan drug status designation for rencofilstat for the treatment of hepatocellular carcinoma.
    • Jaguar Health, Inc. (NASDAQ:JAGX) shares rose 10.7% to $0.2995 in pre-market trading after declining 7% on Friday.
    • Autoliv, Inc. (NYSE:ALV) rose 8.8% to $75.12 in pre-market trading. Autoliv reiterated its full-year 2022 indications.
    • CASI Pharmaceuticals, Inc. (NASDAQ:CASI) rose 8.7% to $3.24 in pre-market trading.
    • Murphy Oil Corporation (NYSE:MUR) rose 8.5% to $36.50 in pre-market trading after declining 7% on Friday.
    • Athersys, Inc. (NASDAQ:ATHX) rose 7.6% to $0.3002 in pre-market trading after declining 13% on Friday.


    Don’t forget to check out our premarket coverage here .

    Losers

    • Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ:BHAT) shares fell 48.2% to $0.60 in pre-market trading. Blue Hat Interactive Entertainment Technology reported a proposed underwritten public offering of ordinary shares and pre-funded warrants to purchase ordinary shares.
    • UTStarcom Holdings Corp. (NASDAQ:UTSI) fell 12.5% to $0.70 in pre-market trading.
    • Electric Last Mile Solutions, Inc. (NASDAQ:ELMS) fell 11.9% to $0.3216 in pre-market trading after surging 29% on Friday. Electric Last Mile recently anounced plans to filed for Chapter 7 bankruptcy.
    • NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) fell 10.1% to $0.38 in pre-market trading.
    • SoundHound AI, Inc. (NASDAQ:SOUN) fell 9.8% to $3.61 in pre-market trading after jumping around 50% on Friday.
    • Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) shares fell 9.2% to $4.03 in pre-market trading. Comera Life Sciences shares jumped around 27% on Friday after the company was granted a US patent titled 'Excipient compounds for protein processing.'
    • COMSovereign Holding Corp. (NASDAQ:COMS) shares fell 9.1% to $0.1585 in pre-market trading.
    • Wah Fu Education Group Limited (NASDAQ:WAFU) shares fell 8.8% to $2.06 in pre-market trading.
    • Motorsport Games Inc. (NASDAQ:MSGM) fell 8.4% to $0.4156 in pre-market trading after declining around 27% on Friday.
    Get the next $ALV alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALV
    $ATHX
    $BHAT
    $CASI

    CompanyDatePrice TargetRatingAnalyst
    Valneva SE
    $VALN
    8/19/2025$18.00Buy
    H.C. Wainwright
    Autoliv Inc.
    $ALV
    7/2/2025$140.00Buy
    Jefferies
    Autoliv Inc.
    $ALV
    6/25/2025$133.00Outperform
    RBC Capital Mkts
    Murphy Oil Corporation
    $MUR
    5/21/2025Accumulate → Hold
    Johnson Rice
    Murphy Oil Corporation
    $MUR
    5/15/2025$25.00Buy → Neutral
    Roth Capital
    Murphy Oil Corporation
    $MUR
    5/13/2025$31.00Outperform → Neutral
    Mizuho
    Autoliv Inc.
    $ALV
    5/9/2025$123.00Neutral → Outperform
    BNP Paribas Exane
    Murphy Oil Corporation
    $MUR
    4/23/2025$32.00 → $24.00Equal Weight → Underweight
    Barclays
    More analyst ratings

    $ALV
    $ATHX
    $BHAT
    $CASI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    UTStarcom Reports Unaudited Financial Results for First Half of 2025

    HANGZHOU, China, Aug. 29, 2025 (GLOBE NEWSWIRE) -- UTStarcom ("UT," "UTStarcom" or the "Company") (NASDAQ:UTSI), a global telecommunications infrastructure provider, today reported its unaudited financial results and a business update for the six months ended June 30, 2025 ("the first half"). Business Highlights: Multi-million dollar China Telecom Research Institute RFP win. UTStarcom has been selected as a major winner of the RFP "Self-developed STN-A Equipment Hardware Production and OEM Procurement Project" from Guangdong Research Institute of China Telecom Co., Ltd ("China Telecom Research Institute") for manufacturing of a large number of disa

    8/29/25 6:15:43 AM ET
    $UTSI
    Telecommunications Equipment
    Telecommunications

    Valneva Announces FDA's Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.

    Saint Herblain (France), August 25, 2025 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced that the United States Food and Drug Administration (FDA) has suspended the license for IXCHIQ®, citing four new reports of serious adverse events (SAEs) consistent with chikungunya-like illness. The suspension of the license is effective immediately and requires Valneva to stop shipping and selling of IXCHIQ® in the United States. The suspension follows the FDA's decision on August 6, 20251 to remove its recommended pause2 in the use of IXCHIQ® in individuals 60 years of age and older based on a thorough investigation of reported SAEs, primarily among elderly indivi

    8/25/25 1:00:00 AM ET
    $VALN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    RedHill Biopharma Awarded $1.8 Million in Legal Costs and Expenses by New York Supreme Court in Addition to its Prior $8.25 Million Summary Judgment Win

    The New York Supreme Court has awarded RedHill approximately $1.82 million in legal costs and expenses following, and in addition to, the Court's prior summary judgment of approximately $8.25 million in favor of RedHill in its action against Kukbo Co. Ltd's ("Kukbo"); the $8.25 million and $1.82 million awards include 9% ongoing statutory interest accrual RALEIGH, N.C. and TEL-AVIV, Israel, Aug. 20, 2025 /PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the New York Supreme Court has awarded RedHill approximately $1.82 million in legal costs and expenses (including interest) in its action against Kuk

    8/20/25 9:00:00 AM ET
    $RDHL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALV
    $ATHX
    $BHAT
    $CASI
    SEC Filings

    View All

    SEC Form 6-K filed by CASI Pharmaceuticals Inc.

    6-K - CASI Pharmaceuticals, Inc. (0001962738) (Filer)

    8/29/25 4:30:23 PM ET
    $CASI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by UTStarcom Holdings Corp.

    6-K - UTSTARCOM HOLDINGS CORP. (0001030471) (Filer)

    8/29/25 6:13:41 AM ET
    $UTSI
    Telecommunications Equipment
    Telecommunications

    SEC Form 6-K filed by CASI Pharmaceuticals Inc.

    6-K - CASI Pharmaceuticals, Inc. (0001962738) (Filer)

    8/27/25 4:30:17 PM ET
    $CASI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALV
    $ATHX
    $BHAT
    $CASI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $ALV
    $ATHX
    $BHAT
    $CASI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    H.C. Wainwright resumed coverage on Valneva SE with a new price target

    H.C. Wainwright resumed coverage of Valneva SE with a rating of Buy and set a new price target of $18.00

    8/19/25 8:36:26 AM ET
    $VALN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Jefferies resumed coverage on Autoliv with a new price target

    Jefferies resumed coverage of Autoliv with a rating of Buy and set a new price target of $140.00

    7/2/25 7:55:32 AM ET
    $ALV
    Auto Parts:O.E.M.
    Consumer Discretionary

    RBC Capital Mkts initiated coverage on Autoliv with a new price target

    RBC Capital Mkts initiated coverage of Autoliv with a rating of Outperform and set a new price target of $133.00

    6/25/25 7:56:35 AM ET
    $ALV
    Auto Parts:O.E.M.
    Consumer Discretionary

    Director Delta John bought $20,426 worth of shares (7,000 units at $2.92) (SEC Form 4)

    4 - Motorsport Games Inc. (0001821175) (Issuer)

    8/21/25 4:05:22 PM ET
    $MSGM
    Computer Software: Prepackaged Software
    Technology

    Director Nolan Jeffrey W bought $233,947 worth of shares (10,000 units at $23.39) (SEC Form 4)

    4 - MURPHY OIL CORP (0000717423) (Issuer)

    3/5/25 4:39:33 PM ET
    $MUR
    Oil & Gas Production
    Energy

    Vice President Palanivelu Meenambigai converted options into 4,946 shares, covered exercise/tax liability with 2,160 shares and bought $41,999 worth of shares (1,573 units at $26.70), increasing direct ownership by 13% to 37,065 units (SEC Form 4)

    4 - MURPHY OIL CORP (0000717423) (Issuer)

    2/6/25 7:26:08 PM ET
    $MUR
    Oil & Gas Production
    Energy

    $ALV
    $ATHX
    $BHAT
    $CASI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Lincoln Alternative Strategies Llc claimed ownership of 600,000 shares (SEC Form 3)

    3 - Jaguar Health, Inc. (0001585608) (Issuer)

    8/29/25 4:05:28 PM ET
    $JAGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: New insider Huang Guoquan claimed ownership of 181,818 shares (SEC Form 3)

    3/A - Motorsport Games Inc. (0001821175) (Issuer)

    8/27/25 4:10:01 PM ET
    $MSGM
    Computer Software: Prepackaged Software
    Technology

    New insider Riaz Atif claimed ownership of 7,521 shares (SEC Form 3)

    3 - MURPHY OIL CORP (0000717423) (Issuer)

    8/25/25 4:37:39 PM ET
    $MUR
    Oil & Gas Production
    Energy

    $ALV
    $ATHX
    $BHAT
    $CASI
    Leadership Updates

    Live Leadership Updates

    View All

    Valneva Announces Exclusive Vaccine Marketing and Distribution Agreement for Germany with CSL Seqirus

    Saint-Herblain, France, June 26, 2025 – Valneva SE, (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced an exclusive agreement with CSL Seqirus, one of the world's largest influenza vaccine companies, for the marketing and distribution of Valneva's three proprietary vaccines in Germany. Under the agreed terms, CSL Seqirus will start commercializing Valneva's single-dose chikungunya vaccine IXCHIQ® from July 2025, and Valneva's Japanese Encephalitis vaccine IXIARO® and cholera/ETEC1 vaccine DUKORAL® from January 2026. This new agreement with CSL Seqirus replaces the marketing and distribution agreement Valneva signed with Bavarian Nordic in 20212, which is due to conclude

    6/26/25 1:00:00 AM ET
    $VALN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY 2025 guidance

    Saint-Herblain (France), June 25, 2025 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Board of Directors were approved by the shareholders at its Annual General Meeting held today in Lyon, France. Among the adopted resolutions were the approval of the 2024 financial statements, delegations for the Board of Directors to increase Valneva's share capital and/or issue financial instruments, the appointment of Dr. Gerd Zettlmeissl to the Board for a three-year term and the reappointment of Mr. James Sulat for a one-year term. Dr. Gerd Zettlmeissl is a vaccine expert and Biotech Entrepreneur with more than 30 years

    6/25/25 11:45:00 AM ET
    $VALN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Autoliv Announces Results of 2025 Annual Stockholders Meeting

    DETROIT, May 8, 2025 /PRNewswire/ -- Autoliv, Inc., (NYSE:ALV) (SSE: ALIV.sdb), the worldwide leader in automotive safety systems, today announced the results of its annual general meeting of stockholders held on May 8, 2025. Annual General Meeting of Stockholders The Company's 2025 Annual General Meeting of Stockholders (AGM) voted for approval of the following proposals: The election of Mikael Bratt, Laurie Brlas, Jan Carlson, Leif Johansson, Adriana Karaboutis, Franz-Josef Kortüm, Frédéric Lissalde, Xiaozhi Liu, Gustav Lundgren, Martin Lundstedt, and Thaddeus "Ted" Senko as directors of the Board for a one-year term ending at the 2026 AGM;The non-binding, advisory resolution to approve t

    5/8/25 5:43:00 PM ET
    $ALV
    Auto Parts:O.E.M.
    Consumer Discretionary

    $ALV
    $ATHX
    $BHAT
    $CASI
    Financials

    Live finance-specific insights

    View All

    Mereo BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Highlights

    Data from Phase 3 Orbit and Cosmic studies of setrusumab in osteogenesis imperfecta expected around year-end 2025 Cash of $56.1 million as of June 30, 2025, expected to support operations into 2027  LONDON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ:MREO) ("Mereo" or the "Company"), a clinical-stage biopharmaceutical company focused on rare diseases, today announced its financial results for the second quarter ended June 30, 2025, and provided recent corporate highlights.  "We look forward to the final analysis for the two ongoing Phase 3 studies for setrusumab in osteogenesis imperfecta, the Phase 3 Orbit study in pediatric and young adult patients, and the Pha

    8/12/25 7:35:56 AM ET
    $MREO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates

    Total revenues of €97.6 million compared to €70.8 million in the first half of 2024Cash and cash equivalents of €161.3 million at end of June 2025Further clinical and regulatory progress2025 financial outlook confirmed Saint-Herblain (France), August 12, 2025 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today reported its condensed consolidated financial results for the first half of the year, ended June 30, 2025, and confirmed its 2025 financial guidance. The half year financial report, including the condensed consolidated interim financial report and the half year management report, is available on the Company's website (Financial Reports – Valneva). Valneva will

    8/12/25 1:00:00 AM ET
    $VALN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Motorsport Games to Report Second Quarter 2025 Financial Results

    MIAMI, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ:MSGM) ("Motorsport Games" or "the Company"), a racing game developer, publisher and esports ecosystem provider of official motorsport racing series, will report its financial results for the second quarter of 2025 on Wednesday, August 13, 2025 after market close. Management will host a conference call and webcast on the same day at 5:00 p.m. ET to discuss the results. Participants may access the webcast on the Company's investor relations website at https://ir.motorsportgames.com under "Events." This webcast will be available live and remain accessible as a recording for 12 months following the date of the ca

    8/7/25 5:39:28 PM ET
    $MSGM
    Computer Software: Prepackaged Software
    Technology

    $ALV
    $ATHX
    $BHAT
    $CASI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Spirit Airlines Inc.

    SC 13G - Spirit Airlines, Inc. (0001498710) (Subject)

    12/6/24 9:37:58 AM ET
    $SAVE
    Air Freight/Delivery Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Mereo BioPharma Group plc

    SC 13G/A - Mereo BioPharma Group plc (0001719714) (Subject)

    11/14/24 4:18:45 PM ET
    $MREO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Hepion Pharmaceuticals Inc.

    SC 13G/A - Hepion Pharmaceuticals, Inc. (0001583771) (Subject)

    11/14/24 4:07:59 PM ET
    $HEPA
    Biotechnology: Pharmaceutical Preparations
    Health Care